Burfiralimab
Product Specifications
CAS Number
2460809-80-5
Target
SARS-CoV, Interleukin, HBV
Related Pathways
Microbiology/Virology, Immunology/Inflammation
Purity
0.952
Bioactivity
Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038089-APC 200 µL
MAP1ALC3 (APG8A/B) (LC3, MAP1LC3B, MAP1ALC3, Microtubule-associated proteins 1A/1B light chain 3B, Autophagy-related protein LC3 B, Autophagy-related ubiquitin-like modifier LC3 B, MAP1 light chain 3-like protein 2, MAP1A/MAP1B light chain 3 B, Microtubule-associated protein 1 light chain 3 beta) (APC) discontinued
Sign In for Pricing
View Details 031330-Biotin 200 µL
VEGFC (VEGFC, Vascular endothelial growth factor C, Flt4 ligand, Vascular endothelial growth factor-related protein) (Biotin)
Sign In for Pricing
View Details 
GTR15239399 1 Vial
Lentiviral mouse Srd5a1 shRNA (UAS) - Lentiviral mouse Srd5a1 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details